Pharmaceuticals, Biotechnology and Life Sciences
– MGTA-117 ADC clinical candidate for conditioning showed broad tolerability and wide pre-clinical safety margins – – MGTA-117 demonstrated robust…
– Updated data from the Phase 1 study in healthy subjects show that MGTA-145, in combination with plerixafor, met all…
MADISON, Wis.–(BUSINESS WIRE)–Promega Corporation, a global biotechnology manufacturer, today launched its new Wizard® HMW DNA Extraction Kit for researchers working…
– ALUNBRIG has Potential to Expand its Indication in ALK+ Metastatic Non-Small Cell Lung Cancer – – Prescription Drug User…
Primary Endpoint of Symptom Control Achieved in Phase 2 Dry Eye Disease Formulation Clinical Trial Statistically Significant Combined Data Across…
Trial to evaluate safety and tolerability of PT101, as well as expansion of regulatory T cells CAMBRIDGE, Mass.–(BUSINESS WIRE)–Pandion Therapeutics,…
SAN DIEGO–(BUSINESS WIRE)–Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure…
Former CEO of Freeline Therapeutics, Ltd. has outstanding international drug development, commercialization expertise, with focus on rare disease, gene therapy…
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of…
Teva’s Digital Inhaler Portfolio Now Includes Products from Three of the Most Commonly Prescribed Classes of Asthma Treatments TEL AVIV…